Control Solution Container
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US D672,051 | Control Solution Container In force · High confidence | Bionostics, Inc. | In force | High confidence | ||
| US D571,928 | Control Solution Container Term ended Term ended Jun 24, 2022 · High confidence | Ferraris Group, Inc. | Term ended | Term ended Jun 24, 2022 | Term ended Jun 24, 2022 | High confidence |
| US D609,362 | Control Solution Container Term ended Term ended Feb 2, 2024 · High confidence | Bionostics, Inc. | Term ended | Term ended Feb 2, 2024 | Term ended Feb 2, 2024 | High confidence |
| US 7,749,453 | Devices, Systems, and Methods for the Containment and Use of Liquid Solutions Term ended Term ended Jun 22, 2025 · High confidence | Ferraris Group, Inc. | Term ended | Term ended Jun 22, 2025 | Term ended Jun 22, 2025 | High confidence |
| US 7,850,923 | Container for Maintaining Stabilized Control Solution and Container for Single-Use Control Solution Including Prior Use Indicator Term ended Term ended Apr 15, 2026 · High confidence | Bionostics, Inc. | Term ended | Term ended Apr 15, 2026 | Term ended Apr 15, 2026 | High confidence |
| Application 11/121,592 | Devices, systems, and methods for the containment and use of liquid solutions Abandoned Abandoned May 20, 2009 | Ferraris Group, Inc. | Abandoned | Abandoned May 20, 2009 | not computed |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Bionostics, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.